Clinical Trials Directory

Trials / Completed

CompletedNCT04063800

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI

Status
Completed
Phase
Study type
Observational
Enrollment
195 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers

Summary

With 50% of post-operative biochemical failure, efficient predictive models are needed to guide post-operative management. Radiomic features are quantitative features extracted from medical imaging, supposed to be correlated with tumor heterogeneity. We aim to build and test three predictive models (clinical, radiomic and combined models).

Conditions

Timeline

Start date
2018-06-26
Primary completion
2018-08-28
Completion
2018-08-28
First posted
2019-08-21
Last updated
2019-09-12

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04063800. Inclusion in this directory is not an endorsement.

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-ther (NCT04063800) · Clinical Trials Directory